Citigroup’s Lombard Medical, Inc. EVAR Stock Holding History

Citigroup’s Portfolio EVAR Stock Details EVAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-420	Closed	–	–	7712
2016 Q1	$0	Buy	+420	New	+$374	﹤0.01%	8011
2014 Q4	–	Sell	-3	Closed	–	–	7481
2014 Q3	$0	Buy	+3	New	+$20	﹤0.01%	7466

Other funds holding EVAR

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TYCC

Texas Yale Capital Corp St. Petersburg, Florida $3.52B AUM 52.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Citigroup's EVAR Position: Q2 2016 in Review

Citigroup sold out of Lombard Medical, Inc. (EVAR) in Q2 2016, closing a stake of 420 shares.

Citigroup first reported a position in EVAR in Q3 2014 and held it in 2 quarters. The position peaked at $0 in Q1 2016. 15 funds tracked by Wall St. Rank hold EVAR as of Q2 2016.

Citigroup reported no remaining Lombard Medical, Inc. position as of Q2 2016 after selling out during the quarter.
Citigroup sold 420 Lombard Medical, Inc. shares in Q2 2016.
Citigroup first reported a position in Lombard Medical, Inc. in Q3 2014 and held it in 2 quarters.
Citigroup's Lombard Medical, Inc. position peaked at $0 in Q1 2016.
15 funds tracked by Wall St. Rank held Lombard Medical, Inc. as of Q2 2016.

Based on Citigroup's 13F filing for Q2 2016, filed 12 Aug 2016.